Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis
This study has been completed.
Study NCT01177800 Information provided by Xian-Janssen Pharmaceutical Ltd.
First Received on August 5, 2010. Last Updated on September 4, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Skin Diseases, Papulosquamous
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Anti-Inflammatory Agents, Non-Steroidal
Central Nervous System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents
Sponsors listed in this trial
Xian-Janssen Pharmaceutical Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers